Skip to Content
 

News: Colorectal Cancer

Study links lifestyle factors to formation of high-risk polyps

Thursday, December 8th, 2016

Lifestyle factors like cigarette smoking and red meat consumption are known to be associated with an increased risk of colon polyps that can lead to colorectal cancer. Polyps are small growths on the lining of the colon, and while some polyps are harmless others can progress to cancer. A new study led by Vanderbilt University […]

Colon cancer awareness event set for Aug. 5

Thursday, July 28th, 2016

For some people cancer, especially colon cancer, is a persistent and potentially deadly visitor affecting family members from one generation to the next. Individuals who have a parent, sibling or child diagnosed with colon cancer have double the risk of developing the disease. But not all colon cancer is caused by hereditary factors. Vanderbilt-Ingram Cancer […]

Precision medicine already changing cancer treatment strategies

Thursday, May 26th, 2016

The ability to test patients’ cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment. “Nationwide we’re seeing great promise with this approach […]

Patient encourages early screening for colon cancer

Friday, April 1st, 2016

Van Edmundson, a retiree from Ashland City, Tennessee, had his first screening colonoscopy at 50, the age recommended for most patients. Individuals with a family history of colorectal cancer or with current gastrointestinal symptoms may need to be screened earlier. Edmundson’s test was negative for colon cancer and he got the all-clear again when he […]

One Million Strong event to raise awareness about colorectal cancer

Thursday, March 17th, 2016

Thousands of colorectal patients, families and supporters will gather in Nashville April 1 and 2 for the annual One Million Strong event to raise awareness about colorectal cancer. The nonprofit organization, Fight Colorectal Cancer, along with community partners including Vanderbilt-Ingram Cancer Center (VICC), will host two days of activities highlighting the importance of colorectal cancer […]

Study explores less invasive way to monitor colorectal cancer

Monday, February 22nd, 2016

Investigators at Vanderbilt University Medical Center have published research regarding an important feature of colorectal cancer (CRC) that could eventually lead to the development of non-invasive means of monitoring cancer progression. After lung cancer, CRC is the second-most lethal cancer in the United States. The team’s research, published in eLIFE, indicates that colorectal cancer cells […]

Study identifies potential colon cancer biomarker

Thursday, February 11th, 2016

A protein that suppresses a key cancer pathway in the colon may be a potential biomarker for colitis-associated tumors, researchers at Vanderbilt University Medical Center reported last month in the journal Gut. The protein, called blood vessel epicardial substance or BVES, also may be a new therapeutic target for cancers in the colon and elsewhere, […]

Ayers Institute spurred key cancer research gains

Friday, November 13th, 2015

In 2005, Tennessee philanthropists Jim and Janet Ayers gave $10 million to help Vanderbilt University scientists find early markers for colorectal cancer that could improve diagnosis and potentially save lives. Within nine years, the gift, which established the Jim Ayers Institute for Precancer Detection and Diagnosis at the Vanderbilt-Ingram Cancer Center (VICC), had yielded an […]

Hach shows age not always a barrier to cancer therapy

Thursday, September 3rd, 2015

Phila Hach recently celebrated her 89th birthday and she has had much to celebrate over the years. “I have a wonderful life. I’ve had an exotic life, an eclectic life,” explained Hach. It is a life that recently included chemotherapy to address advanced colon cancer. Emily Chan, M.D., Ph.D., associate professor of Medicine and a […]

New type of trial shows promise for several cancers

Monday, August 24th, 2015

Anti-cancer drugs are typically tested on one type of cancer at a time. But an international consortium of cancer investigators, including Vanderbilt-Ingram Cancer Center (VICC) researchers, simultaneously tested an existing therapy in patients with several different forms of cancer that all exhibit the same tumor gene mutation. The new clinical trial showed promising results in […]

Next Page »« Previous Page